Research indicates that plasma IL-6 levels are higher in moderate HD than in early-stage or premanifest HD, and a meta-analysis demonstrated significantly elevated levels in mutation-positive individuals compared with controls [94]. The gene discussed is IL6; the disease is Huntington disease.